Filing Details

Accession Number:
0001628280-25-029368
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-04 16:40:24
Reporting Period:
2025-06-02
Filing Date:
2025-06-04
Accepted Time:
2025-06-04 16:40:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1104506 Insmed Inc INSM Pharmaceutical Preparations (2834) 541972729
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1402051 William Lewis 700 Us Highway 202/206
Bridgewater NJ 08807
Chair And Ceo Yes Yes No No
Transaction Summary
Sold: 12,302 shares Avg. Price: $71.39 Total Value: $878,292.20
Number of Shares After Transactions: 308,758 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-06-02 6,830 $10.85 240,754 No 4 M Indirect By the Katie Procter Dynasty Trust
Common Stock Disposition 2025-06-02 1,000 $70.23 239,754 No 4 S Indirect By the Katie Procter Dynasty Trust
Common Stock Disposition 2025-06-02 4,400 $71.35 235,354 No 4 S Indirect By the Katie Procter Dynasty Trust
Common Stock Disposition 2025-06-02 1,430 $71.94 233,924 No 4 S Indirect By the Katie Procter Dynasty Trust
Common Stock Disposition 2025-06-03 5,472 $71.50 308,758 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect By the Katie Procter Dynasty Trust
No 4 S Indirect By the Katie Procter Dynasty Trust
No 4 S Indirect By the Katie Procter Dynasty Trust
No 4 S Indirect By the Katie Procter Dynasty Trust
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2025-06-02 6,830 $0.00 6,830 $10.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
157,160 2026-05-19 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 50,500 Indirect By the William Lewis Family Legacy Trust
Footnotes
  1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. This is the weighted average sales price representing 1,000 shares sold at prices ranging from $69.59 to $70.57 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  3. This is the weighted average sales price representing 4,400 shares sold at prices ranging from $70.67 to $71.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. This is the weighted average sales price representing 1,430 shares sold at prices ranging from $71.67 to $72.24 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
  6. The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.